Related Experiment Video
Updated: Aug 2, 2026
09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Hepatitis-like syndrome induced by nimesulide?
1Divisione di Malattie Infettive, Ca' Foncello Hospital, Treviso, Italy.
Le Infezioni in Medicina
|July 8, 2003
Summary
Nimesulide, a nonsteroidal anti-inflammatory drug, was linked to significant liver enzyme elevations in a teenage patient. This case highlights potential hepatotoxicity associated with Nimesulide use.
Area of Science:
- Hepatology
- Clinical Pharmacology
- Adverse Drug Reactions
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation management.
- Hepatotoxicity is a known, albeit rare, adverse effect associated with some NSAIDs.
- Nimesulide is an NSAID with a specific pharmacological profile, and its safety profile, particularly regarding liver function, warrants ongoing evaluation.
Purpose of the Study:
- To report a case of recurrent significant elevation of serum transaminases in a young patient following Nimesulide administration.
- To investigate the potential association between Nimesulide and drug-induced liver injury (DILI).
- To raise awareness among clinicians regarding the potential hepatotoxic effects of Nimesulide.
Main Methods:
- Case report detailing the clinical presentation, laboratory findings, and treatment course of a 17-year-old female patient.
- Review of patient's medical history, focusing on medication intake, specifically Nimesulide (per os).
- Monitoring of serum transaminase levels (e.g., ALT, AST) before and after Nimesulide administration.
Main Results:
- The patient presented with symptoms of weakness and malaise.
- Significant elevations in serum transaminases were observed on two separate occasions within one month.
- These elevations temporally correlated with the administration of Nimesulide.
Conclusions:
- Nimesulide administration may be associated with drug-induced liver injury, characterized by elevated serum transaminases.
- The recurrent nature of the transaminase increase suggests a potential causal link with Nimesulide exposure.
- Further investigation and cautious monitoring are recommended for patients, especially young individuals, receiving Nimesulide.
Related Concept Videos
01:17Hepatic Drug Excretion: Enterohepatic Cycling
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...